1. Home
  2. TWST

TWST

Twist Bioscience Corporation

Logo Twist Bioscience Corporation

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.

Founded: 2013 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 2.0B IPO Year: 2018
Target Price: $34.60 AVG Volume (30 days): 888.4K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.61 EPS Growth: N/A
52 Week Low/High: $11.46 - $43.21 Next Earning Date: 05-03-2024
Revenue: $262,364,000 Revenue Growth: 21.58%
Revenue Growth (this year): 22.03% Revenue Growth (next year): 20.76%

Share on Social Networks: